» Articles » PMID: 11462044

Effective Human Herpesvirus 8 Infection of Human Umbilical Vein Endothelial Cells by Cell-mediated Transmission

Overview
Journal J Virol
Date 2001 Jul 20
PMID 11462044
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Cell-free transmission of human herpesvirus 8 (HHV-8) to human cells in vitro has been reported to be difficult, if not impossible. The present experiments were conducted with the idea that cell-cell contact may produce much more effective transmission, so-called cell-mediated transmission. Primary human umbilical vein endothelial cells (HUVECs) were cocultured with an HHV-8-infected lymphoma cell line, BCBL-1 cells. When a ratio of 12-O-tetradecanoylphorbol-13-acetate (TPA)-treated BCBL-1 cells to HUVECs of 10:1 was used, more than 20% of HUVECs were found to express the HHV-8 latency-associated nuclear antigen (LANA) 48 h after the start of coculturing; this value increased to more than 30% after 72 h. HHV-8-encoded ORF26, K8, K8.1, K10, K11, ORF59, and ORF65 proteins were not detected in these HHV-8-infected HUVECs until 72 h. The HHV-8 antigens were not observed in HUVECs cocultured with TPA-treated BCBL-1 cells separated by a membrane. Thirty days after removal of the BCBL-1 cells from the cell-mediated transmission experiment, the HUVECs still expressed LANA and the HHV-8 genome was detected by PCR in these cells. Moreover, the ORF59 protein, a DNA replication-associated protein of HHV-8, was expressed in such HUVECs in the presence of TPA stimulation. These results indicated a far more effective transmission mechanism, cell-cell contact, suggesting the possibility that such a mechanism works in vivo.

Citing Articles

A Case of Kaposi's Sarcoma Associated with Disseminated AIDS: The Management Challenges.

Shi J, Ying G, Zhang Z Infect Drug Resist. 2023; 16:6367-6374.

PMID: 37789840 PMC: 10544134. DOI: 10.2147/IDR.S428945.


Virus-Driven Carcinogenesis.

Hatano Y, Ideta T, Hirata A, Hatano K, Tomita H, Okada H Cancers (Basel). 2021; 13(11).

PMID: 34071792 PMC: 8198641. DOI: 10.3390/cancers13112625.


3D culture conditions support Kaposi's sarcoma herpesvirus (KSHV) maintenance and viral spread in endothelial cells.

Dubich T, Dittrich A, Bousset K, Geffers R, Busche G, Koster M J Mol Med (Berl). 2021; 99(3):425-438.

PMID: 33484281 PMC: 7900040. DOI: 10.1007/s00109-020-02020-8.


Systemically circulating viral and tumor-derived microRNAs in KSHV-associated malignancies.

Chugh P, Sin S, Ozgur S, Henry D, Menezes P, Griffith J PLoS Pathog. 2013; 9(7):e1003484.

PMID: 23874201 PMC: 3715412. DOI: 10.1371/journal.ppat.1003484.


Pathology of Kaposi's Sarcoma-Associated Herpesvirus Infection.

Fukumoto H, Kanno T, Hasegawa H, Katano H Front Microbiol. 2011; 2:175.

PMID: 21904536 PMC: 3161246. DOI: 10.3389/fmicb.2011.00175.


References
1.
Katano H, Iwasaki T, Baba N, Terai M, Mori S, Iwamoto A . Identification of antigenic proteins encoded by human herpesvirus 8 and seroprevalence in the general population and among patients with and without Kaposi's sarcoma. J Virol. 2000; 74(8):3478-85. PMC: 111855. DOI: 10.1128/jvi.74.8.3478-3485.2000. View

2.
Harrington Jr W, Bagasra O, Sosa C, Bobroski L, Baum M, Wen X . Human herpesvirus type 8 DNA sequences in cell-free plasma and mononuclear cells of Kaposi's sarcoma patients. J Infect Dis. 1996; 174(5):1101-5. DOI: 10.1093/infdis/174.5.1101. View

3.
Beckstead J, Wood G, FLETCHER V . Evidence for the origin of Kaposi's sarcoma from lymphatic endothelium. Am J Pathol. 1985; 119(2):294-300. PMC: 1887903. View

4.
Dittmer D, Stoddart C, Renne R, Moreno M, Bare C, McCune J . Experimental transmission of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to SCID-hu Thy/Liv mice. J Exp Med. 1999; 190(12):1857-68. PMC: 2195708. DOI: 10.1084/jem.190.12.1857. View

5.
Friborg Jr J, Kong W, Hottiger M, Nabel G . p53 inhibition by the LANA protein of KSHV protects against cell death. Nature. 2000; 402(6764):889-94. DOI: 10.1038/47266. View